1. Hypoxic Signaling Is Modulated by Calcium Channel, CaV1.3, in Androgen-Resistant Prostate Cancer
   Debbie O'Reilly et al, 2022, Bioelectricity CrossRef
2. Specific and reliable detection of Myosin 1C isoform A by RTqPCR in prostate cancer cells
   Aleena A. Saidova et al, 2018, PeerJ CrossRef
3. Prostatic aspirated cellular RNA analysis enables fast diagnosis and staging of prostate cancer
   Yiwen Sang et al, 2021, Translational Oncology CrossRef
4. The MYH9 Cytoskeletal Protein Is a Novel Corepressor of Androgen Receptors
   Chunhua Liu et al, 2021, Frontiers in Oncology CrossRef
5. USP54 is a potential therapeutic target in castration-resistant prostate cancer
   Cheng Zhou et al, 2024, BMC Urology CrossRef
6. Therapy-induced lipid uptake and remodeling underpin ferroptosis hypersensitivity in prostate cancer
   Kaylyn D. Tousignant et al, 2020, Cancer & Metabolism CrossRef
7. CaV1.3 enhanced store operated calcium promotes resistance to androgen deprivation in prostate cancer
   Debbie O'Reilly et al, 2022, Cell Calcium CrossRef
8. Unveiling a pH-Responsive Dual-Androgen-Blocking Magnetic Molecularly Imprinted Polymer for Enhanced Synergistic Therapy of Prostate Cancer
   Xueyi Liu et al, 2024, ACS Applied Materials & Interfaces CrossRef
9. Juglone suppresses epithelial‑mesenchymal transition in prostate cancer cells via the protein kinase B/glycogen synthase kinase‑3β/Snail signaling pathway
   Fang Fang et al, 2018, Oncology Letters CrossRef
10. Identification and Validation of Three Hub Genes Involved in Cell Proliferation and Prognosis of Castration-Resistant Prostate Cancer
    Pan Yu et al, 2022, Oxidative Medicine and Cellular Longevity CrossRef
11. A functional genomics screen reveals a strong synergistic effect between docetaxel and the mitotic gene DLGAP5 that is mediated by the androgen receptor
    Kay Hewit et al, 2018, Cell Death & Disease CrossRef
12. Targeting the TLK1/NEK1 DDR axis with Thioridazine suppresses outgrowth of androgen independent prostate tumors
    Vibha Singh et al, 2019, International Journal of Cancer CrossRef
13. The transcriptional factor ZEB1 represses Syndecan 1 expression in prostate cancer
    Nancy Farfán et al, 2018, Scientific Reports CrossRef
14. Loading of ”cocktail siRNAs” into extracellular vesicles via TAT-DRBD peptide for the treatment of castration-resistant prostate cancer
    Yanjun Diao et al, 2022, Cancer Biology & Therapy CrossRef
15. Clinical response in metastatic castration‐resistant prostate cancer (mCRPC) cases treated with supra‐physiological doses of testosterone: Bipolar androgen therapy
    Senji Hoshi et al, 2022, Clinical Case Reports CrossRef
16. Osteoblasts Generate Testosterone From DHEA and Activate Androgen Signaling in Prostate Cancer Cells
    Henry H Moon et al, 2020, Journal of Bone and Mineral Research CrossRef
17. Could the kinetin riboside be used to inhibit human prostate cell epithelial–mesenchymal transition?
    Joanna Dulińska-Litewka et al, 2020, Medical Oncology CrossRef
18. Targeting Prostate Cancer, the ‘Tousled Way’
    Siddhant Bhoir et al, 2023, International Journal of Molecular Sciences CrossRef
19. The metabolic role of PFKFB4 in androgen-independent growth in vitro and PFKFB4 expression in human prostate cancer tissue
    Ximing Li et al, 2020, BMC Urology CrossRef